These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 30019510)
1. Cancer of unknown primary-Epidemiological trends and relevance of comprehensive genomic profiling. Binder C; Matthes KL; Korol D; Rohrmann S; Moch H Cancer Med; 2018 Sep; 7(9):4814-4824. PubMed ID: 30019510 [TBL] [Abstract][Full Text] [Related]
2. Age-Dependent Metastatic Spread and Survival: Cancer of Unknown Primary as a Model. Hemminki K; Pavlidis N; Tsilidis KK; Sundquist K; Ji J Sci Rep; 2016 Mar; 6():23725. PubMed ID: 27009354 [TBL] [Abstract][Full Text] [Related]
3. Time trends in survival from cancer of unknown primary: small steps forward. Riihimäki M; Hemminki A; Sundquist K; Hemminki K Eur J Cancer; 2013 Jul; 49(10):2403-10. PubMed ID: 23518210 [TBL] [Abstract][Full Text] [Related]
4. Exploring the epidemiological characteristics of cancers of unknown primary site in an Australian population: implications for research and clinical care. Luke C; Koczwara B; Karapetis C; Pittman K; Price T; Kotasek D; Beckmann K; Brown MP; Roder D Aust N Z J Public Health; 2008 Aug; 32(4):383-9. PubMed ID: 18782405 [TBL] [Abstract][Full Text] [Related]
5. Cancer patients without a known primary: incidence and survival trends in Sweden 1960-2007. Randén M; Rutqvist LE; Johansson H Acta Oncol; 2009; 48(6):915-20. PubMed ID: 19363713 [TBL] [Abstract][Full Text] [Related]
6. Time trends in incidence, causes of death, and survival of cancer of unknown primary in Sweden. Shu X; Sundquist K; Sundquist J; Hemminki K Eur J Cancer Prev; 2012 May; 21(3):281-8. PubMed ID: 21968687 [TBL] [Abstract][Full Text] [Related]
7. Adherence to the World Cancer Research Fund and the American Institute for Cancer Research lifestyle recommendations for cancer prevention and Cancer of Unknown Primary risk. Hermans KEPE; van den Brandt PA; Loef C; Jansen RLH; Schouten LJ Clin Nutr; 2022 Feb; 41(2):526-535. PubMed ID: 35026689 [TBL] [Abstract][Full Text] [Related]
8. Cancer of unknown primary: Incidence rates, risk factors and survival among adolescents and young adults. Pavlidis N; Rassy E; Smith-Gagen J Int J Cancer; 2020 Mar; 146(6):1490-1498. PubMed ID: 31144291 [TBL] [Abstract][Full Text] [Related]
9. Descriptive epidemiology of cancer of unknown primary site in Scotland, 1961-2010. Brewster DH; Lang J; Bhatti LA; Thomson CS; Oien KA Cancer Epidemiol; 2014 Jun; 38(3):227-34. PubMed ID: 24726751 [TBL] [Abstract][Full Text] [Related]
10. Cancers of Unknown Primary Origin: Real-World Clinical Outcomes and Genomic Analysis at the European Institute of Oncology. Boscolo Bielo L; Belli C; Crimini E; Repetto M; Ascione L; Pellizzari G; Santoro C; Fuorivia V; Barberis M; Fusco N; Rocco EG; Curigliano G Oncologist; 2024 Jun; 29(6):504-510. PubMed ID: 38520742 [TBL] [Abstract][Full Text] [Related]
11. Real-world data analysis of patients with cancer of unknown primary. Kang S; Jeong JH; Yoon S; Yoo C; Kim KP; Cho H; Ryoo BY; Jung J; Kim JE Sci Rep; 2021 Nov; 11(1):23074. PubMed ID: 34845302 [TBL] [Abstract][Full Text] [Related]
12. Sarcomatoid carcinoma presenting as cancers of unknown primary: a clinicopathological portrait. Huey RW; Makawita S; Xiao L; Matamoros A; Estrella JS; Overman MJ; Varadhachary GR; Raghav K BMC Cancer; 2019 Oct; 19(1):965. PubMed ID: 31623602 [TBL] [Abstract][Full Text] [Related]
13. Cancer of Unknown Primary in Adolescents and Young Adults: Clinicopathological Features, Prognostic Factors and Survival Outcomes. Raghav K; Mhadgut H; McQuade JL; Lei X; Ross A; Matamoros A; Wang H; Overman MJ; Varadhachary GR PLoS One; 2016; 11(5):e0154985. PubMed ID: 27171493 [TBL] [Abstract][Full Text] [Related]
14. Identification and survival outcomes of a cohort of patients with cancer of unknown primary in Ontario, Canada. Kim CS; Hannouf MB; Sarma S; Rodrigues GB; Rogan PK; Mahmud SM; Winquist E; Brackstone M; Zaric GS Acta Oncol; 2015 Nov; 54(10):1781-7. PubMed ID: 25825957 [TBL] [Abstract][Full Text] [Related]
15. Comparison of survival of patients with metastases from known versus unknown primaries: survival in metastatic cancer. Riihimäki M; Thomsen H; Hemminki A; Sundquist K; Hemminki K BMC Cancer; 2013 Jan; 13():36. PubMed ID: 23356713 [TBL] [Abstract][Full Text] [Related]
16. The currently declining incidence of cancer of unknown primary. Rassy E; Pavlidis N Cancer Epidemiol; 2019 Aug; 61():139-141. PubMed ID: 31254795 [TBL] [Abstract][Full Text] [Related]
17. Familial Risk in Patients With Carcinoma of Unknown Primary. Samadder NJ; Smith KR; Hanson H; Pimentel R; Wong J; Boucher K; Akerley W; Gilcrease G; Ulrich CM; Burt RW; Curtin K JAMA Oncol; 2016 Mar; 2(3):340-6. PubMed ID: 26863281 [TBL] [Abstract][Full Text] [Related]
18. Clinical and immune profiling for cancer of unknown primary site. Haratani K; Hayashi H; Takahama T; Nakamura Y; Tomida S; Yoshida T; Chiba Y; Sawada T; Sakai K; Fujita Y; Togashi Y; Tanizaki J; Kawakami H; Ito A; Nishio K; Nakagawa K J Immunother Cancer; 2019 Sep; 7(1):251. PubMed ID: 31519206 [TBL] [Abstract][Full Text] [Related]
19. Rapid reduction in the incidence of cancer of unknown primary. A population-based study. Brustugun OT; Helland Å Acta Oncol; 2014 Jan; 53(1):134-7. PubMed ID: 23550957 [TBL] [Abstract][Full Text] [Related]
20. An audit of cancer of unknown primary notifications: A cautionary tale for population health research using cancer registry data. Vajdic CM; Er CC; Schaffer A; Dobbins T; Wyld L; Meagher NS; Barrett J; Ward RL; Pearson SA Cancer Epidemiol; 2014 Aug; 38(4):460-4. PubMed ID: 24929356 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]